Global proteome and phosphoproteome alterations in third generation EGFR TKI resistance reveal drug targets to circumvent resistance
X. Zhang, T. Maity, K. Ross, Y. Qi, C. Cultraro, S. Gao, K. D. Nguyen, J. Cowart, F. Kirkali, C. Wu, U. Guha
The paper analyzes proteome and phosphoproteome changes in EGFR TKI-resistant lung cancer cells to identify drug targets that can overcome resistance.
bioRxiv · Jul 4, 2020Cancer Biology